CN Patent

CN105111191B — 一种用于合成cdk9抑制剂的关键中间体及其制备方法和用途

Assigned to Shanghai Haohong Biomedical Technology Co.,Ltd. · Expires 2018-06-08 · 8y expired

What this patent protects

本发明涉及一种制备CDK9抑制剂关键中间体其合成方法及使用该中间体制备CDK9抑制剂的方法，特别是合成LY2857785的方法。该合成方法起始原料以及反应试剂廉价易得，整条合成路线反应条件温和，收率高。

USPTO Abstract

本发明涉及一种制备CDK9抑制剂关键中间体其合成方法及使用该中间体制备CDK9抑制剂的方法，特别是合成LY2857785的方法。该合成方法起始原料以及反应试剂廉价易得，整条合成路线反应条件温和，收率高。

Drugs covered by this patent

Patent Metadata

Patent number
CN105111191B
Jurisdiction
CN
Classification
—
Expires
2018-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Haohong Biomedical Technology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.